GLP-1 Market
LLY $1409.38 ▼ -0.1% NVO $40.19 ▼ -0.6% PFE $30.00 ▼ -2.2% VKTX $26.09 ▼ -2.8% KLRA $12.58 ▲ +3.5% GPCR $20.35 ▼ -0.6% RHHBY $59.18 ▼ -2.5%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Lipid Lowering Medication

Company
University of Colorado, Denver
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
4 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

4 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Nov 4, 2026

Find a Clinical Trial Near Me

See recruiting studies for Lipid Lowering Medication and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT05482386

    STREAM Trial - Biomarker

    Not yet reported Insel Gruppe AG, University Hospital Bern 500 participants Est. completion 2026-11 1 site
    Other conditions: Statin Treatment for Primary Prevention
    View official trial listing →
  • Recruiting NCT NCT05482399

    STREAM Trial - Subclinical Atherosclerosis

    Not yet reported Insel Gruppe AG, University Hospital Bern 500 participants Est. completion 2026-11 1 site
    Other conditions: Statin Treatment for Primary Prevention
    View official trial listing →
  • Recruiting NCT NCT06804980

    DESIFOR-EXPAND (MHIF)

    Not yet reported Minneapolis Heart Institute Foundation 100 participants Est. completion 2026-12-31 1 site
    Other conditions: Statin Therapy, Statin Adverse Reaction, Statin
    View official trial listing →
  • Recruiting NCT NCT06975111

    Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

    Not yet reported, Not yet reported University of Colorado, Denver 200 participants Est. completion 2030-10-01 3 sites
    Other conditions: Menopause, Menopause Hot Flashes, Menopause Related Conditions, Cardiovascular
    View official trial listing →
  • Completed NCT NCT00217919

    Reducing Risk Factors in Peripheral Arterial Disease

    Not yet reported Northwestern University 355 participants Est. completion 2009-11 2 sites
    Cardiovascular disease Other conditions: Peripheral Vascular Diseases
    View official trial listing →
  • Withdrawn NCT NCT00572442

    Magnetocardiography (MCG) in Asymptomatic Individuals - Pilot Trial

    Cedars-Sinai Medical Center 40 participants Est. completion 2009-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00704444

    A 12-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244)

    Organon and Co 11332 participants Est. completion 2009-09
    Other conditions: Hypercholesterolemia, Familial Hypercholesterolemia, Homozygous Sitosterolemia
    View official trial listing →
  • Completed NCT NCT00705211

    A 52-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05245)

    Organon and Co 1794 participants Est. completion 2009-12
    Other conditions: Hypercholesterolemia, Familial Hypercholesterolemia, Homozygous Sitosterolemia
    View official trial listing →
  • Status unknown NCT NCT00711984

    Comparison of Stenting Versus Best Medical Therapy for Treatment of Ostial Renal Artery Stenosis: a Trial in Patients With Advanced Atherosclerosis

    Not yet reported Medical University of Vienna 120 participants 1 site
    Other conditions: Renal Artery Stenosis
    View official trial listing →
  • Completed NCT NCT00848224

    Improving Adherence to Pharmacological Treatment

    Not yet reported University of Massachusetts, Worcester 689 participants Est. completion 2005-05 1 site
    Other conditions: Medication Adherence
    View official trial listing →
  • Status unknown NCT NCT00876330

    Improving Antihypertensive and Lipid-Lowering Therapy

    Not yet reported VA Boston Healthcare System 6000 participants Est. completion 2013-03
    Other conditions: Hyperlipidemia, Hypertension
    View official trial listing →
  • Completed NCT NCT01516151

    Assess the Safety and Efficacy of NKPL66 (CaPre™) in the Treatment of Mild-to-high Hypertriglyceridemia

    Not yet reported Grace Therapeutics Inc. 289 participants Est. completion 2013-09 38 sites
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT01564485

    Cardiac CT's Role in Asymptomatic Patients With Diabetes and Metabolic Syndrome

    Not yet reported University of California, Irvine 193 participants Est. completion 2016-12 1 site
    Metabolic syndrome Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01699126

    The Endothelium Dysfunction in Patients of Obstructive Sleep Apnea Syndrome

    Not yet reported Chang Gung Memorial Hospital 46 participants Est. completion 2013-08 1 site
    Other conditions: Sleep Apnea, Obstructive
    View official trial listing →
  • Completed NCT NCT01881971

    Statins for Pulmonary and Cardiac Complications of Chronic HIV - Coordinating Center

    Not yet reported Alison Morris 23 participants Est. completion 2016-01 3 sites
    Other conditions: HIV Seropositivity
    View official trial listing →
  • Completed NCT NCT02927808

    Motivational Interviewing to Support LDL-C Therapeutic Goals and Lipid-Lowering Therapy Compliance in Patients With Acute Coronary Syndromes: a Prospective Randomized Clinical Study

    Not yet reported AHEPA University Hospital 360 participants Est. completion 2020-04 1 site
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Terminated NCT NCT03820466

    Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive Troponin

    Not yet reported Dr. med. Mahir Karakas 68 participants Est. completion 2022-04-07 7 sites Stand-alone
    Other conditions: Acute Chest Syndrome
    View official trial listing →
  • Completed NCT NCT04835571

    CARotid Mri of Atherosclerosis

    Not yet reported Linkoeping University 52 participants Est. completion 2021-12-31 Stand-alone
    Other conditions: Carotid Stenosis, Carotid Artery Plaque, Carotid Atherosclerosis
    View official trial listing →
  • Status unknown NCT NCT05029661

    Ultrasound Elastography for Individual Carotid Plaque Stratification

    Radboud University Medical Center 100 participants Est. completion 2023-01-01 1 site
    Other conditions: Carotid Artery Plaque
    View official trial listing →
  • Completed NCT NCT05178420

    STREAM Trial - Statins in Multimorbid Older Adults Without Cardiovascular Disease

    Not yet reported Insel Gruppe AG, University Hospital Bern 1880 participants Est. completion 2026-04-30 24 sites
    Other conditions: Statin Treatment for Primary Prevention
    View official trial listing →
  • Active, not recruiting NCT NCT05684055

    "Community-based, eHealth Supported Management of Cardiovascular Risk Factors by Lay Village Health Workers (ComBaCaL aHT TwiC 1 & ComBaCaL aHT TwiC 2)

    Not yet reported University Hospital, Basel, Switzerland 1354 participants Est. completion 2027-12-31 2 sites
    Other conditions: Arterial Hypertension
    View official trial listing →
  • Active, not recruiting NCT NCT05743387

    Community-based, eHealth Supported Type 2 Diabetes Care by Lay Village Health Workers in Rural Lesotho

    Not yet reported University Hospital, Basel, Switzerland 252 participants Est. completion 2027-12-31 2 sites
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT06614049

    AdLip: Human Coach-supported Digital/AI Personal Health Assistant to Improve Adherence to Lipid-Lowering Medication

    Not yet reported National University of Singapore 450 participants Est. completion 2026-02-14 2 sites
    Other conditions: Hyperlipidemia, Medication Nonadherence
    View official trial listing →
  • Completed NCT NCT06740552

    Evolocumab in Patients With Multivessel Coronary Disease After Acute Myocardial Infarction: A Target Trial Emulation

    Shanghai Zhongshan Hospital 1862 participants Est. completion 2025-10-31 1 site
    Cardiovascular disease
    View official trial listing →
  • Not yet recruiting NCT NCT07064135

    Improved Medication and Care to Achieve Lipid Targets After Carotid Surgery

    Not yet reported Barmherzige Brüder Linz 50 participants Est. completion 2026-12 1 site
    Other conditions: Dyslipidaemias, Carotid Artery Stenoses
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Lipid Lowering Medication, The use of generic statins

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.